Foghorn Therapeutics Inc. 344174107 06/24/2026 To approve, on an advisory basis, the compensation of Foghorn's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 11 0 FOR 11 FOR Foghorn Therapeutics Inc. 344174107 06/24/2026 To approve, on an advisory basis, the frequency of future advisory votes on the compensation of Foghorn's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 11 0 FOR 11 FOR Structure Therapeutics Inc. 86366E106 06/17/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 90801 0 FOR 90801 FOR Zai Lab Limited 98887Q104 06/17/2026 THAT, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement, is hereby approved SECTION 14A SAY-ON-PAY VOTES ISSUER 253 0 ABSTAIN 0 FOR Palisade Bio, Inc. 696389402 06/10/2026 To approve the Amended and Restated Palisade Bio, Inc. 2021 Equity Incentive Plan COMPENSATION ISSUER 10367427 0 FOR 10367427 FOR Palisade Bio, Inc. 696389402 06/10/2026 To approve the Amended and Restated Palisade Bio, Inc. 2021 Employee Stock Purchase Plan COMPENSATION ISSUER 10367427 0 FOR 10367427 FOR Palisade Bio, Inc. 696389402 06/10/2026 To approve equity award grants to our non-employee directors COMPENSATION ISSUER 10367427 0 FOR 10367427 FOR Iovance Biotherapeutics, Inc. 462260100 06/10/2026 To approve, by non-binding advisory vote, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 2417 0 FOR 2417 FOR Iovance Biotherapeutics, Inc. 462260100 06/10/2026 To approve, by non-binding advisory vote, the frequency of our future votes on the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 2417 0 FOR 2417 FOR Palisade Bio, Inc. 696389402 06/10/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 10367427 0 FOR 10367427 FOR Praxis Precision Medicines, Inc. 74006W207 06/10/2026 To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 12273 0 FOR 12273 FOR Apogee Therapeutics, Inc. 03770N101 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES ISSUER 0 0 FOR 0 FOR Assembly Biosciences, Inc. 045396207 06/04/2026 Approval of an amendment to the Amended and Restated 2018 Stock Incentive Plan to increase the number of shares reserved for issuance by 1,200,000 shares COMPENSATION ISSUER 150162 0 FOR 150162 FOR Assembly Biosciences, Inc. 045396207 06/04/2026 Approval of an amendment to the Second Amended and Restated 2018 Employee Stock Purchase Plan to increase the authorized shares reserved for issuance to 515,000 shares COMPENSATION ISSUER 150162 0 FOR 150162 FOR Assembly Biosciences, Inc. 045396207 06/04/2026 Approval, on a non-binding advisory basis, of our named executive officers' compensation SECTION 14A SAY-ON-PAY VOTES ISSUER 150162 0 FOR 150162 FOR ADMA Biologics, Inc. 000899104 06/02/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 3198949 0 FOR 3198949 FOR Oruka Therapeutics, Inc. 687604108 06/02/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 67174 0 FOR 67174 FOR Taysha Gene Therapies, Inc. 877619106 06/01/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 1778755 0 FOR 1778755 FOR Taysha Gene Therapies, Inc. 877619106 06/01/2026 To indicate, on a non-binding advisory basis, the preferred frequency of future stockholder advisory votes on the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 1778755 0 FOR 1778755 FOR NRx Pharmaceuticals, Inc. 629444209 03/23/2026 Approve Amendment 1 to the NRx Pharmaceuticals, Inc. 2021 Omnibus Incentive Plan COMPENSATION ISSUER 3000000 0 AGAINST 3000000 FOR NRx Pharmaceuticals, Inc. 629444209 03/23/2026 Non-binding advisory vote on the compensation of named executive officers (fiscal year 2024) SECTION 14A SAY-ON-PAY VOTES ISSUER 3000000 0 FOR 3000000 FOR